Leukemia

In this interview, Naval Daver, MD, discusses a session on myelodysplastic syndrome from Society of Hematologic Oncology Annual Meeting.

Naval Daver, MD, spoke with Healio about updates in FLT3-mutated acute myeloid leukemia from Society of Hematologic Oncology Annual Meeting.

In this episode of Meeting Mic, we bring you pearls and perspectives from the 2024 European Society for Medical Oncology Congress with a focus on leukemia.

In this video, Douglas Tremblay, MD, discusses the results of a study into a first-line treatment of chronic myelomonocytic leukemia presented at ESMO Congress 2024.

In this video, Rosalie Griffin, PhD, discusses the results of a study into point mutations and their correlation with developing blood cancers presented at ESMO Congress 2024.

In this video, Rosalie Griffin, PhD, discusses the results of a study she presented at ESMO Congress 2024, which examined a biomarker that could indicate a person’s risk for developing blood cancer.

In this video, Naval Daver, MD, discusses a presentation on updates in immune and cellular therapy in acute myeloid leukemia from Society of Hematologic Oncology Annual Meeting.

Healio spoke with Naval Daver, MD, about a debate on the best duration of venetoclax in combination with azacitidine among older patients with acute myeloid leukemia from Society of Hematologic Oncology Annual Meeting.

Healio spoke with Naval Daver, MD, about presentations on the use of molecular therapies, including menin inhibitors, in the treatment of acute myeloid leukemia from Society of Hematologic Oncology Annual Meeting.

Many patients with chronic lymphocytic leukemia or non-Hodgkin lymphoma do not undergo immunoglobulin G testing despite its potential to reduce likelihood of severe infections.